New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Assembly Biosciences, Inc.
ASMB
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

107M

Biotechnology

Next Earning date - 13 Nov 2024

107M

Biotechnology

Next Earning date - 13 Nov 2024

16.91USD
Shape-0.02 ( -0.12%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-16%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated October 27, 2024
1W 1.93 % 1M 11.69 % 3M 16.46 % 1Y 61.97 %

Key Metrics

Shape
  • Market Cap

    107.30M


  • Shares Outstanding

    6.35M


  • Share in Float

    4.49M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    16.91


  • Average Volume

    25731


  • Beta

    0.643


  • Range

    7.68-19.93


  • Industry

    Biotechnology


  • Website

    https://www.assemblybio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.00x

P/S Ratio

2.75x

P/B Ratio

0.1

Debt/Equity

-212.3%

Net Margin

$-8.9

EPS

How ASMB compares to sector?

P/E Ratio

Relative Strength

Shape

ASMB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$38M

Shape342%

2025-Revenue

$6.95

Shape-251%

2025-EPS

$21M

Shape-74%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2024-09-20

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-5.76
vs -4.92

Q4.22

arrow
arrow

N/A

-5.52
vs -4.92

Q1.23

arrow
arrow

N/A

-4.44
vs -5.76

Q2.23

arrow
arrow

N/A

-3.84
vs -6.12

Q3.23

arrow
arrow

N/A

-3.24
vs -5.76

Q4.23

arrow
arrow

N/A

-2.15
vs -5.52

Q1.24

arrow
arrow

N/A

-1.66
vs -4.44

Q2.24

arrow
arrow

N/A

-1.98
vs -3.84

Q3.24

arrow
arrow

N/A

-2.30
vs -3.24

Q4.24

arrow
arrow

N/A

-2.07
vs -2.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-100%

NA  vs 6.3M

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

7.2M  vs NA

Q1.24

arrow
arrow

NA

5.8M  vs NA

Q2.24

arrow
arrow

NA

8.5M  vs NA

Q3.24

arrow
arrow

NA

5.8M  vs NA

Q4.24

arrow
arrow

-18%

5.9M  vs 7.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-22%

-0.22
vs -0.20

Q4.22

arrow
arrow

-26%

-0.26
vs -0.22

Q1.23

arrow
arrow

-26%

-0.26
vs -0.26

Q2.23

arrow
arrow

-31%

-0.31
vs -0.26

Q3.23

arrow
arrow

-35%

-0.35
vs -0.31

Q4.23

arrow
arrow

-27%

-0.27
vs -0.35

Q1.24

arrow
arrow

-28%

-0.28
vs -0.27

Q2.24

arrow
arrow

-32%

-0.32
vs -0.28

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

54

54
vs 53

2%

Q3.22

arrow
arrow

48

48
vs 54

-11%

Q4.22

arrow
arrow

39

39
vs 48

-19%

Q1.23

arrow
arrow

37

37
vs 39

-5%

Q2.23

arrow
arrow

31

31
vs 37

-16%

Q3.23

arrow
arrow

32

32
vs 31

3%

Q4.23

arrow
arrow

44

44
vs 32

38%

Q1.24

arrow
arrow

1

1
vs 44

-98%

Earnings Growth

Latest News